Former Prime Minister’s Cannabis Company Delivers 170% Sales Boost
INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter. The
INTERCURE is predicting revenues of C$100m (£59m) over the coming year after reporting record sales in its third quarter. The
4C LABS has become the first and only company to be awarded a medical cannabis cultivation licence in Guernsey marking
IRELAND now has its first patient through the state-approved Medical Cannabis Access Programme (MCAP) some four years after it was
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards
OCT believes Stemtech’s technology provides an in vitro translational model that will better predict results in humans.
Drug policy specialist Natalie O’Regan on Ireland’s faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched
UK Market-listed cannabis business Kanabo is now generating its first revenues following the successful launch of its flagship VapePod product.
SUGGESTIONS that CBD is a fad – a boom-to-bust market – with the latter imminent, raised a few eyebrows at
DESPITE coming under increasing pressure to unblock the medical cannabis prescribing impasse the UK Government this week continued to distance
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.